Alkermes PLC
ALKSHealthcare|Drug Manufacturers - Specialty & Generic|Ireland
$51.95
-1.82 (-3.39%)
DCF (FCF)
$20.11
Earnings Power
$12.19
About
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Stock Price
+70.6%(1Y)
Pipeline Summary
115 total trials27
Phase 1
27
Phase 2
48
Phase 3
10
Phase 4
Completed: 96Terminated: 8Recruiting: 9NOT_YET_RECRUITING: 1ENROLLING_BY_INVITATION: 1
Active Trials (9)
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
NCT07540897Narcolepsy Type 1
Phase 3Recruiting
Enrollment: 150 participants
Neuroplasticity in Maternal Opioid Use Disorder (OUD)
NCT05495984Opioid Use Disorder
N/ARecruiting
Enrollment: 15 participants
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
NCT06767683Narcolepsy Type 1
Phase 2Phase 3Recruiting
Enrollment: 256 participants
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
NCT05303064Schizophrenia
Phase 3Recruiting
Enrollment: 220 participants
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
NCT06843590Idiopathic Hypersomnia
Phase 2Recruiting
Enrollment: 126 participants
BioScore
4.7/10
Cautious
Ownership
Recent Insider Trades
Gaffin David JosephSELL
2026-07-062,034 shares @ $54.03
Hopkinson Craig C.SELL
2026-07-019,000 shares @ $51.51
Wright Christopher ISELL
2026-06-122,000 shares @ $45.1
Gaffin David JosephSELL
2026-06-042,034 shares @ $43.05
Hopkinson Craig C.SELL
2026-06-019,000 shares @ $41.67
Recent News
2026-07-10 21:30:49
2026-07-07 00:00:21
2026-07-02 12:17:13
2026-06-29 23:07:05
2026-06-29 14:05:57
Data last updated: Jul 12, 2026, 07:30 PM